USA - NASDAQ:ELTX - US28657F1030 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ELTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Jones Trading | Initiate | Buy |
| 2024-08-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-01 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-01-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
8 analysts have analysed ELTX and the average price target is 15.81 USD. This implies a price increase of 72.79% is expected in the next year compared to the current price of 9.15.
The consensus rating for ELICIO THERAPEUTICS INC (ELTX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ELICIO THERAPEUTICS INC (ELTX) is 8.